WHO TMF guidance – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Sat, 13 Sep 2025 00:54:30 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for TMF Setup (Paper/eTMF) and Structure https://www.clinicalstudies.in/sop-for-tmf-setup-paper-etmf-and-structure/ Sat, 13 Sep 2025 00:54:30 +0000 ]]> https://www.clinicalstudies.in/?p=7015 Read More “SOP for TMF Setup (Paper/eTMF) and Structure” »

]]>
SOP for TMF Setup (Paper/eTMF) and Structure

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-tmf-setup-paper-etmf-and-structure”
},
“headline”: “SOP for TMF Setup (Paper/eTMF) and Structure”,
“description”: “This SOP establishes standardized processes for setting up Trial Master Files (TMF), both paper and electronic (eTMF), ensuring compliance with ICH GCP, FDA, EMA, CDSCO, and WHO requirements for clinical trial documentation structure, indexing, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for TMF Setup (Paper/eTMF) and Structure

SOP No. CR/OPS/074/2025
Supersedes NA
Page No. 1 of 36
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to describe the standardized setup, structure, and maintenance of the Trial Master File (TMF), whether maintained in paper format or electronic format (eTMF). TMF serves as the central repository of essential documents demonstrating compliance with Good Clinical Practice (GCP) and enabling evaluation by regulatory authorities.

Scope

This SOP applies to sponsors, CROs, investigator sites, and QA staff responsible for establishing, maintaining, and overseeing TMF/eTMF systems. It covers setup, indexing, placeholders, document classification, version control, user access, quality checks, and inspection readiness across all clinical trials.

Responsibilities

  • Sponsor: Ensures TMF/eTMF is established, structured, and compliant with ICH GCP.
  • CRO: May maintain TMF on behalf of sponsor but sponsor retains oversight responsibility.
  • Clinical Operations: Files trial-related documents, ensures contemporaneous updates.
  • QA: Audits TMF/eTMF for compliance and completeness.
  • TMF Administrator: Manages indexing, placeholders, user access, and quality checks.
  • Investigators: Ensure ISF aligns with sponsor TMF.

Accountability

The sponsor is accountable for TMF/eTMF compliance, regardless of outsourcing. TMF administrators and CROs are accountable for daily management, while QA ensures oversight and audit readiness.

Procedure

1. TMF/eTMF Setup
1.1 At trial initiation, establish a TMF in accordance with ICH E6 (R2/R3) §8 Essential Documents.
1.2 Define TMF structure using recognized models (e.g., DIA TMF Reference Model).
1.3 For eTMF, validate the system in compliance with 21 CFR Part 11 and Annex 11.
1.4 Create TMF/eTMF Index (Annexure-1) reflecting trial phases: before, during, and after the trial.
1.5 Ensure placeholders are created for expected documents, reducing missing documentation risk.

2. Document Classification and Filing
2.1 Classify each document as Essential Before, During, or After trial per ICH GCP.
2.2 Assign document owners responsible for timely filing.
2.3 File documents within 5 working days of finalization.
2.4 Apply version control; superseded versions archived with audit trail.
2.5 Scan and upload paper documents into eTMF if hybrid system used.

3. User Access and Security
3.1 Provide role-based access controls for TMF/eTMF.
3.2 Ensure inspectors have read-only access when required.
3.3 Maintain Access Control Log (Annexure-2).

4. Quality Control and Completeness Checks
4.1 Perform monthly QC checks on 10% of documents across sections.
4.2 Document QC results in TMF QC Log (Annexure-3).
4.3 Rectify discrepancies within 10 working days.
4.4 Perform quarterly completeness reviews using DIA TMF metrics.

5. Version Management and Audit Trails
5.1 Ensure all eTMF documents have audit trails (creation, modification, deletion).
5.2 For paper TMFs, apply dated/stamped superseded labels.
5.3 Maintain TMF Audit Trail Log (Annexure-4).

6. Inspection Readiness
6.1 TMF/eTMF must be inspection-ready at all times.
6.2 Maintain TMF Inspection Checklist (Annexure-5).
6.3 Ensure essential documents (consent, approvals, monitoring reports, IP accountability) are contemporaneous.
6.4 Provide controlled access for regulators within 5 working days of request.

7. Archiving and Migration
7.1 Archive TMF/eTMF at trial closeout in secure, access-controlled facility.
7.2 Retain documents for 15–25 years depending on jurisdiction.
7.3 Document any migration from paper to eTMF or between systems with validation and reconciliation records.

Abbreviations

  • SOP: Standard Operating Procedure
  • TMF/eTMF: Trial Master File / electronic Trial Master File
  • QC: Quality Control
  • QA: Quality Assurance
  • DIA: Drug Information Association
  • PI: Principal Investigator
  • ISF: Investigator Site File

Documents

  1. TMF/eTMF Index (Annexure-1)
  2. Access Control Log (Annexure-2)
  3. TMF QC Log (Annexure-3)
  4. TMF Audit Trail Log (Annexure-4)
  5. TMF Inspection Checklist (Annexure-5)

References

Version: 1.0

Approval Section

Prepared By Rajesh Kumar, TMF Administrator
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Quality

Annexures

Annexure-1: TMF/eTMF Index

Section Document Type Status
Before Trial Protocol, IB, Approvals Filed
During Trial Monitoring reports, IP logs Filed
After Trial Closeout report, Archival plan Pending

Annexure-2: Access Control Log

User Role Access Level Date Assigned Date Revoked
Meena Sharma CRA Read/Write 01/09/2025
Inspector (FDA) Regulator Read-only 15/09/2025 20/09/2025

Annexure-3: TMF QC Log

Date Section Reviewed By Findings Action Taken
10/09/2025 During Trial QA Officer 2 missing CRFs Filed corrected versions

Annexure-4: TMF Audit Trail Log

Date User Action Document Remarks
12/09/2025 CRA Uploaded Monitoring Report Validated
13/09/2025 QA Corrected IP Accountability Log Version 2

Annexure-5: TMF Inspection Checklist

Item Status Remarks
Consent forms filed Yes All versions present
Monitoring reports complete Yes Up to date
IP accountability logs Partial To be reconciled

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Quality

For more SOPs visit: Pharma SOP

]]>